Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Theranostics
|
August 4, 2025
Tetrahydromagnolol induces autophagic cell death by targeting the m<sup>6</sup>A reader protein YTHDF2 and enhances the efficacy of anti-PD-1 immunotherapy in pancreatic cancer cells
Guohua Li, Qibiao Wu, Yiping Mou, et al.
Frontiers in Immunology
|
April 1, 2026
The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization
Deepak Nagra, Benjamin Zuckerman, Joy Odia, et al.
Rheumatology (Oxford, England)
|
June 4, 2024
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study
Deepak Nagra, Katie Bechman, Mark D Russell, et al.
Rheumatology (Oxford, England)
|
June 30, 2025
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literature
Deepak Nagra, Kaiyang Song, Joy Odia, et al.
The Lancet Regional Health. Europe
|
April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study
Katie Bechman, Mark D Russell, Kathryn Biddle, et al.
Vaccines
|
January 22, 2024
No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort
Deepak Nagra, Katie Bechman, Mark D Russell, et al.
The Lancet. Rheumatology
|
October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study
Mark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology
|
February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply
Mark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Rheumatology (Oxford, England)
|
November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study
Mark D Russell, Zijing Yang, Niamh Dooley, et al.
Journal of Hepatology
|
November 15, 2024
Genetic study of intrahepatic cholestasis of pregnancy in Chinese women unveils East Asian etiology linked to historic HBV epidemic
Yanhong Liu, Yuandan Wei, Xiaohang Chen, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Theranostics
|
August 4, 2025
Tetrahydromagnolol induces autophagic cell death by targeting the m<sup>6</sup>A reader protein YTHDF2 and enhances the efficacy of anti-PD-1 immunotherapy in pancreatic cancer cells
Guohua Li, Qibiao Wu, Yiping Mou, et al.
Frontiers in Immunology
|
April 1, 2026
The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization
Deepak Nagra, Benjamin Zuckerman, Joy Odia, et al.
Rheumatology (Oxford, England)
|
June 4, 2024
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study
Deepak Nagra, Katie Bechman, Mark D Russell, et al.
Rheumatology (Oxford, England)
|
June 30, 2025
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literature
Deepak Nagra, Kaiyang Song, Joy Odia, et al.
The Lancet Regional Health. Europe
|
April 18, 2025
Incidence, prevalence, and mortality of sarcoidosis in England: a population-based study
Katie Bechman, Mark D Russell, Kathryn Biddle, et al.
Vaccines
|
January 22, 2024
No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort
Deepak Nagra, Katie Bechman, Mark D Russell, et al.
The Lancet. Rheumatology
|
October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study
Mark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology
|
February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' reply
Mark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
Rheumatology (Oxford, England)
|
November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study
Mark D Russell, Zijing Yang, Niamh Dooley, et al.
Journal of Hepatology
|
November 15, 2024
Genetic study of intrahepatic cholestasis of pregnancy in Chinese women unveils East Asian etiology linked to historic HBV epidemic
Yanhong Liu, Yuandan Wei, Xiaohang Chen, et al.
Page
of 10